Stay updated on Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-11-02T12:34:22.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page displays an NIH notice about a terminology transition, while the prior 403 error is no longer shown. No trial details are visible.
    Difference
    2%
    Check dated 2026-10-26T12:37:09.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2; the study record page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T13:32:06.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:16:51.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Access to the study record is now blocked by a 403 Forbidden error. The page displays a generic error layout instead of the study information.
    Difference
    21%
    Check dated 2026-09-21T20:25:20.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This reflects a minor internal update or maintenance version rather than a change to displayed content.
    Difference
    0.0%
    Check dated 2026-08-31T17:14:15.000Z thumbnail image

Stay in the know with updates to Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.